FDA approved new medical device for treatment of epilepsy

The US epileptic patients who do not react to treatment by standard medicinal products have been given a new opportunity of therapy.

After the three-month clinical testing (with two-year follow-up) the US Food and Drug Administration has approved a medical device reducing frequency of epileptic fits. It is a small neurostimulator implanted into the skull. If you are interested in a more detailed information about the RNS stimulator, read the whole paper.


Register for receiving PharmaAround news, register for PharmAround events.
Continue registration